Sheehan suicidality tracking scale (Sheehan-STS): Preliminary results from a multicenter clinical trial in generalized anxiety disorder

Psychiatry

Volumn 6, Issue 1, 2009, Pages

  Coric, Vladimir ^a,b,c   Stock, Elyse G ^c   Pultz, Joseph ^c   Marcus, Ronald ^c   Sheehan, David V ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale OCD Research Clinic   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Assessment of suicidal behaviors; Suicide; Suicide rating scale; Treatment emergent suicidality

Indexed keywords

BMS 562086; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; ESCITALOPRAM; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GENERALIZED ANXIETY DISORDER; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SELF REPORT; SENSITIVITY AND SPECIFICITY; SHEEHAN SUICIDALITY TRACKING SCALE; SUICIDAL BEHAVIOR; SUICIDAL IDEATION;

EID: 65549167301     PISSN: 15505952     EISSN: 15555194     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Centers for Disease Control dnd Prevention, National Center for Injury Prevention and Control. Web-based Injury Statistics Query and Reporting System (WISQARS). www.cdc.gov/ncipc/wisqars. Access date: December 10, 2008.
2. American Psychiatric Association. Practice Guideline for the Psychiatric Evaluation of Adults, Second Edition. Washington, DC: American Psychiatric Press Inc., 2005.
3. American Psychiatric Association. Practice Guideline for the Assessment and Treatment of Patients with Suicidal Behaviors. Washington, DC: American Psychiatric Press Inc., 2003.
4. Posner K, Oquendo M, Gould M, et al. Columbia Classification Algorithm of Suicide Assessment (C CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry. 2007;165:1035-1043.
5. Hammand TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63(3):246-248.
6. Gibbons RD, Brown CH, Hur K, et al. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry. 2007;164:1356-1363.
7. Bridge JA, Greenhouse JB, Weldon AH, et al. Suicide trends among youths aged 10 to 19 years in the United States, 1996-2005. JAMA. 2008;300(9):1025-1026.
8. Sheehan DV, Lecrubier Y, Harnett-Sheehan K, et al. The MINI International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview. J Clin Psychiatry. 1998;59(suppl 20):22-33.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Press Inc, 2003.
10. Hamilton, M. The assessment of anxiety by rating. Br J Med Psychol. 1959;32:50-55.
11. Coric V, Stock EG, Pultz J, et al. A multicenter, randomized, double-blind, active-comparator and placebo-controlled trial of a corticotropin releasing factor receptor-1 antagonist in generalized Anxiety Disorder. Submitted for publication, 2008.
12. Kaplan, ML, Asnis GM, Sanderson WC, et al. Suicide assessment: clinical interview vs. self-report. J Clin Psychol. 1994;50(2):294-298.
13. Greist JH, Gustafson DH, Stauss FF, et al. A computer interview for suicide-risk prediction. Am J Psychiatry. 1973;130:1328-1332.
14. Erdman HP, Greist JH, Gustafson DH, et al. Suicide risk prediction by computer interview: a prospective study. J Clin Psychiatry. 1987;48(12):464-467.